Invasive Prostate Carcinoma — Trials

Invasive Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

440 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 139
Recruiting: 65
Ph III recruiting: 5
Growth YoY: —
Industry share: 4%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03535675	Muscadine Plus (MPX) In Men With Prostate Cancer	terminated	Phase 3	59	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	May 22, 2023	clinicaltrials
NCT05744115	Ga-68-PSMA-11 in Men With Prostate Cancer(Ga68-PSMA-11)	terminated	Phase 3	38	Timothy HoffmanFED	1	Feb 24, 2023	clinicaltrials